Andrew John Oakley
CIK: 0002059152
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (66.7%)
Compensation grants
Other (G, F, J, C, D, …)1 (33.3%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
About Oakley Andrew John
Oakley Andrew John (SEC CIK 0002059152) files insider reports with the SEC as Director of Tribeca Strategic Acquisition Corp. (BID) and Director of Onconetix, Inc. (ONCO).
Signal8 holds 4 ownership filings by Oakley Andrew John (2 Form 3, 2 Form 4), filed between Mar 7, 2025 and May 28, 2026. Those filings report 3 transactions, from Mar 23, 2025 to Aug 15, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Oakley Andrew John's filings is in NEW YORK, NY.
Recent filings by Oakley Andrew John
Other insiders filing for Tribeca Strategic Acquisition Corp. (BID)
- Tribeca Strategic Partners Holdco LLC, 10% Owner
- Tomba Mattia, Director
- Dunham Gilbert H Jr., Director
- Dange Mihir Vikas, Director